pyrazolanthrone has been researched along with Cerebral Malaria in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anand, SS; Babu, PP; Maruthi, M | 1 |
1 other study(ies) available for pyrazolanthrone and Cerebral Malaria
| Article | Year |
|---|---|
The specific, reversible JNK inhibitor SP600125 improves survivability and attenuates neuronal cell death in experimental cerebral malaria (ECM).
Topics: Animals; Anthracenes; Cell Death; Enzyme Inhibitors; Female; Humans; Inflammation; Malaria, Cerebral; Male; MAP Kinase Kinase 4; Mice; Mice, Inbred C57BL; Neurons; Plasmodium berghei; Survival Analysis; Treatment Outcome | 2013 |